Joon Lee
Stock Analyst at Truist Securities
(2.34)
# 951
Out of 5,240 analysts
124
Total ratings
48.15%
Success rate
31.49%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
argenx | Reiterates: Strong Buy | 660 700 | 665.84 | 5.13% | 12 | Jan 14, 2025 | |
Axsome Therapeutics | Maintains: Strong Buy | 150 180 | 84.66 | 112.62% | 3 | Jan 13, 2025 | |
Solid Biosciences | Initiates Coverage On: Buy | 16 | 3.11 | 414.47% | 1 | Jan 8, 2025 | |
Verona Pharma | Reiterates: Strong Buy | 44 57 | 48.51 | 17.5% | 6 | Jan 8, 2025 | |
Vertex Pharmaceutica... | Maintains: Buy | 550 460 | 411 | 11.92% | 2 | Dec 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 17 36 | 11.13 | 223.45% | 3 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 30 36 | 22.15 | 62.53% | 7 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 8 | 1.14 | 601.75% | 7 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 13 8 | 7.46 | 7.24% | 11 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 17 | 11.22 | 51.52% | 7 | Oct 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 60 60 | n/a | n/a | 2 | Oct 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 65 76 | 51.62 | 47.23% | 7 | Sep 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 118 90 | 63.78 | 41.11% | 2 | Sep 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 40 | 4.36 | 817.43% | 6 | Aug 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 100 | 38.34 | 160.82% | 4 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 120 | 9.68 | 1139.67% | 3 | Jun 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 10 | 0.54 | 1751.85% | 7 | Jun 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 120 | 33.96 | 253.36% | 7 | Jun 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 150 150 | 66 | 127.27% | 3 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 65 | 17.2 | 277.91% | 5 | Mar 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 200 | 123.1 | 62.47% | 2 | Mar 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 5 | 1.64 | 204.88% | 7 | Sep 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 5.04 | 257.14% | 1 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 25 | n/a | n/a | 2 | Sep 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Aug 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 280 | 2.91 | 9521.99% | 1 | Oct 20, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 45 50 | n/a | n/a | 1 | Aug 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 360 | 0.33 | 108990.91% | 2 | Mar 18, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 27 34 | 14.94 | 127.58% | 1 | Mar 16, 2021 |